| Patents for C07D 471 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups (64,559) |
|---|
| 01/30/2014 | US20140031544 Aryl-and heteroarylcarbonyl derivatives of hexahydroindenopyridine and octahydrobenzoquinoline |
| 01/30/2014 | US20140031362 Tri - and tetracyclic pyrazolo[3,4-b]pyridine compounds as antineoplastic agent |
| 01/30/2014 | US20140031360 Bicyclic compounds as pim inhibitors |
| 01/30/2014 | US20140031358 Quinazolinediones and their use |
| 01/30/2014 | US20140031349 Inhibitors of the renal outer medullary potassium channel |
| 01/30/2014 | US20140031345 Quinazolines as potassium ion channel inhibitors |
| 01/30/2014 | US20140031344 Azepine inhibitors of janus kinases |
| 01/30/2014 | US20140031333 Compounds and compositions as c-kit kinase inhibitors |
| 01/30/2014 | US20140031330 ARYL SULTAM DERIVATIVES AS RORc MODULATORS |
| 01/30/2014 | US20140031329 Substituted dihydropyrazolones for treating cardiovascular and hematological diseases |
| 01/30/2014 | US20140030172 2,9-dipyridyl-1,10-phenanthroline derivatives useful as actinide ligands, method for synthesizing same, and uses thereof |
| 01/30/2014 | CA2876508A1 Spiro-fused piperidine derivatives for use as inhibitors of the renal outer medullary potassium channel |
| 01/29/2014 | EP2690102A1 Bicyclic aza-amides for treatment of psychiatric disorders |
| 01/29/2014 | EP2690101A1 5-Anilinoimidazopyridines and Methods of Use |
| 01/29/2014 | EP2689780A1 Intermediates for aminodihydrothiazine derivatives substituted with a cyclic group |
| 01/29/2014 | EP2688887A1 Fused tricyclic dual inhibitors of cdk 4/6 and flt3 |
| 01/29/2014 | EP2688567A1 Autophagy inducing compound and use thereof |
| 01/29/2014 | EP2516437B1 Disubstituted heteroaryl-fused pyridines |
| 01/29/2014 | EP2435435B1 Pyrimidine inhibitors of kinase activity |
| 01/29/2014 | EP2410857B1 P2x3, receptor antagonists for treatment of pain |
| 01/29/2014 | EP2401269B1 Indole derivatives as crth2 receptor antagonists |
| 01/29/2014 | EP2089388B1 Process for the synthesis of moxifloxacin hydrochloride |
| 01/29/2014 | EP2078010B1 Polycyclic heteroaryl substituted triazoles useful as axl inhibitors |
| 01/29/2014 | CN103547638A Polymer-bonded quaterrylene and/or terrylene dyes and compositions containing same |
| 01/29/2014 | CN103547578A 2,9-dipyridyl-1,10-phenanthroline derivatives useful as actinide ligands, method for synthesizing same, and uses thereof |
| 01/29/2014 | CN103547566A Aminoindane compounds and use thereof in treating pain |
| 01/29/2014 | CN103539796A Preparation method of levo praziquantel as well as intermediate thereof |
| 01/29/2014 | CN103539795A Apixaban polymorph and preparation method thereof |
| 01/29/2014 | CN103539784A Heterocyclic benzamide compounds, pharmaceutical compositions as well as application thereof |
| 01/29/2014 | CN103539726A Novel compound with electron injection and/or electron transport capabilities and organic light-emitting device including the same |
| 01/29/2014 | CN102348702B Bi- and tricyclic indazole-substituted 1,4-dihydropyridine derivatives and uses thereof |
| 01/29/2014 | CN101835779B Purine derivatives useful as PI3 kinase inhibitors |
| 01/29/2014 | CN101801958B Heterocyclic amide compounds as protein kinase inhibitors |
| 01/28/2014 | US8637671 Indole derivatives as CRTH2 receptor antagonists |
| 01/28/2014 | US8637670 Imidazo [4,5-C]quinoline derivatives and their use in the treatment of tumors and/or inflammation |
| 01/28/2014 | US8637531 Pyrido(3,2-d)pyridmidines useful for treating viral infections |
| 01/28/2014 | US8637517 Organic compounds |
| 01/28/2014 | US8637513 Heterocycle phenyl amide T-type calcium channel antagonists |
| 01/28/2014 | US8637509 Azaindazoles |
| 01/28/2014 | US8637497 AZA spiro alkane derivatives as inhibitors of metalloproteases |
| 01/28/2014 | CA2617213C Pharmaceutical compositions for the prevention and treatment of complex diseases and their delivery by insertable medical devices |
| 01/28/2014 | CA2580749C Quinolone analogs |
| 01/28/2014 | CA2535265C Compositions and methods for the treatment of disease associated with trp-p8 expression |
| 01/23/2014 | WO2014015291A1 FUSED PYRIMIDINES AS INHIBITORS OF p97 COMPLEX |
| 01/23/2014 | WO2014014962A1 5ht3 receptor antagonists |
| 01/23/2014 | WO2014014951A1 5-ht3 receptor antagonists |
| 01/23/2014 | WO2014014901A1 Octahydro-cyclopentapyrrolyl antagonists of ccr2 |
| 01/23/2014 | WO2014014874A1 Pyrazole derivatives which inhibit leukotriene production |
| 01/23/2014 | WO2014013721A1 Nitrogen-containing heteroaromatic ring compound and organic electroluminescence element using same |
| 01/23/2014 | WO2014013507A1 A process for the preparation of tunable fluorescent polymer composition |
| 01/23/2014 | WO2014013182A1 Imidazopyridine derivative used in the treatment of diabetes |
| 01/23/2014 | WO2014012614A1 Fused triazole derivatives as gamma secretase modulators |
| 01/23/2014 | WO2014012511A1 N-(3-heteroarylaryl)-4-arylarylcarboxamtdes and analogs as hedgehog pathway inhibitors and use thereof |
| 01/23/2014 | US20140024834 Process and intermediates for the synthesis of 8-[-methyl]-8-phenyl-1,7-diaza-spiro[4.5]decan-2-one compounds |
| 01/23/2014 | US20140024678 Stable laquinimod preparations |
| 01/23/2014 | US20140024672 Azaindole derivatives as cftr modulators |
| 01/23/2014 | US20140024671 Compositions and methods for inhibiting cytochrome p450 |
| 01/23/2014 | US20140024661 Fused pyrimidines and substituted quinazolines as inhibitors of p97 |
| 01/23/2014 | US20140024654 Poly (adp-ribose) polymerase (parp) inhibitors |
| 01/23/2014 | US20140024646 Octahydro-cyclopentapyrrolyl antagonists of ccr2 |
| 01/23/2014 | US20140024643 Bridged heterocyclic compounds and methods of use |
| 01/23/2014 | US20140024637 Benzoxazepines as Inhibitors of PI3K/mTOR and Methods of Their use and Manufacture |
| 01/23/2014 | US20140024634 Indazoles |
| 01/23/2014 | US20140023643 N4-phenyl-quinazoline-4-amine derivatives and related compounds as erbb type i receptor tyrosine kinase inhibitors for the treatment of hyperproliferative diseases |
| 01/23/2014 | US20140023642 1-(Arylmethyl)quinazoline-2,4(1H,3H)-diones as PARP Inhibitors and the Use Thereof |
| 01/23/2014 | US20140023636 Aminocarboxylic acid derivative and medicinal use thereof |
| 01/23/2014 | US20140023614 Substituted fused tricyclic compounds, compositions and medicinal applications thereof |
| 01/22/2014 | EP2687533A2 Acrylamide derivatives as FAB I inhibitors |
| 01/22/2014 | EP2687531A1 Tetrahydrocarboline derivative |
| 01/22/2014 | EP2687530A1 Nitrogen-containing aromatic compounds and organic electroluminescent elements |
| 01/22/2014 | EP2687529A1 Condensed heterocyclic compound |
| 01/22/2014 | EP2687528A1 Fused triazole derivatives as gamma secretase modulators |
| 01/22/2014 | EP2687518A1 Nitrogen-containing saturated heterocyclic compound |
| 01/22/2014 | EP2686318A1 Pyrrolopyridineamino derivatives as mps1 inhibitors |
| 01/22/2014 | EP2686302A1 Sulfonamide compounds having trpm8 antagonistic activity |
| 01/22/2014 | EP2685978A2 Cyclohexane substituted amino cyclopentane derivatives as useful ccr2 antagonists |
| 01/22/2014 | EP2685828A1 Substituted 3-azabicyclo[3.1.0]hexane derivatives useful as ccr2 antagonists |
| 01/22/2014 | CN103534254A Tri- and tetracyclic pyrazolo[3,4-b]pyridine compounds as antineoplastic agent |
| 01/22/2014 | CN103534253A Novel compound having affinity for amyloid |
| 01/22/2014 | CN103529667A Electrophotographic photosensitive member, method for producing electrophotographic photosensitive member, process cartridge, electrophotographic apparatus, and imide compound |
| 01/22/2014 | CN103524510A Novel organic electroluminescent compounds and organic electroluminescent device using the same |
| 01/22/2014 | CN103524502A Preparation method of tadalafil |
| 01/22/2014 | CN103524501A Preparation method of 5-azaindoline |
| 01/22/2014 | CN103524492A Quinolones compound with side chain containing nitroimidazole group substitution as well as preparation and use thereof |
| 01/22/2014 | CN103524421A Novel naphthoyl urea derivate and medical application thereof |
| 01/22/2014 | CN103524414A Bridge ring derivative with aza-decadiene structure segment and synthesis method thereof |
| 01/22/2014 | CN103524392A Azetidines as mek inhibitors for the treatment of proliferative diseases |
| 01/22/2014 | CN102827146B Fluoroquinolone acetal ftivazide as well as preparation method and application thereof |
| 01/22/2014 | CN102099358B Compound with serotoninergic activity, process for preparing same and pharmaceutical composition comprising same |
| 01/22/2014 | CN101677569B 2-cyanophenyl fused heterocyclic compounds, and compositions and uses thereof |
| 01/22/2014 | CN101583614B Polycyclic agents for the treatment of respiratory syncytial virus infections |
| 01/21/2014 | US8633319 7-(1H-pyrazol-4-yl)-1,6-naphthyridine compounds as Syk inhibitors |
| 01/21/2014 | US8633318 Compounds for treatment or prevention of inflammation, an inflammatory disease, or an immune or an autoimmune disorder |
| 01/21/2014 | US8633315 Substituted hydroxyethyl amine compounds as beta-secretase modulators and methods of use |
| 01/21/2014 | US8633210 Triazole compounds useful as protein kinase inhibitors |
| 01/21/2014 | US8633196 Benzenesulfonamide compounds, method for synthesizing same, and use thereof in medicine as well as in cosmetics |
| 01/16/2014 | WO2014011568A1 Azaindole derivatives which act as pi3k inhibitors |
| 01/16/2014 | WO2014010732A1 Heterocyclic compound |
| 01/16/2014 | WO2014010602A1 Indolecarboxamide derivative |
| 01/16/2014 | WO2014010305A1 Compound, solar cell module, and solar power generation device |